TIMOTHY BYERS: Open Payments
NPI 1467563320 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 8 companies in 2025. Trend: 2023 $245 · 2024 $624 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $43 |
| AtriCure, Inc. | 1 | $30 |
| Amgen Inc. | 2 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| ABIOMED | 1 | $17 |
| Octapharma USA, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Wegovy, ATRICLIP LAA EXCLUSION SYSTEM, REPATHA, Kerendia, WAINUA, FIBRYGA, VERQUVO.
Industry payments across MO — which companies pay providers there.
